Details for New Drug Application (NDA): 208912

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 208912 describes DEXYCU KIT, which is a drug marketed by Eyepoint Pharms and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the DEXYCU KIT profile page.

The generic ingredient in DEXYCU KIT is dexamethasone. There are thirty-nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.

Summary for 208912

Tradename:	DEXYCU KIT
Applicant:	Eyepoint Pharms
Ingredient:	dexamethasone
Patents:	7
Formulation / Manufacturing:	see details

Pharmacology for NDA: 208912

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for 208912

Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents, Hormonal
Glucocorticoids

Suppliers and Packaging for NDA: 208912

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DEXYCU KIT	dexamethasone	SUSPENSION;INTRAOCULAR	208912	NDA	EyePoint Pharmaceuticals US, Inc	71879-001	71879-001-01	1 VIAL, GLASS in 1 CARTON (71879-001-01) / .5 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SUSPENSION;INTRAOCULAR			Strength	9%
Approval Date:	Feb 9, 2018	TE:		RLD:	Yes
Patent:	⤷ Try a Trial	Patent Expiration:	Jun 22, 2034	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF POSTOPERATIVE INFLAMMATION
Patent:	⤷ Try a Trial	Patent Expiration:	May 23, 2034	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF POSTOPERATIVE INFLAMMATION
Patent:	⤷ Try a Trial	Patent Expiration:	May 23, 2034	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 208912

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eyepoint Pharms	DEXYCU KIT	dexamethasone	SUSPENSION;INTRAOCULAR	208912-001	Feb 9, 2018	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.